Mother diagnosed with terminal stomach cancer after mistaking symptom for side effect of diet - Mother-of-four Camilla ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist ...

The FDA has approved Keytruda plus chemotherapy in HER2+ gastric or GEJ adenocarcinoma with PD-L1–positive expression, based on KEYNOTE-811 data.

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

Teresa Tiano was diagnosed with stomach cancer in 2011. Now she's helping others Canadians with "the orphan cancer." ...

An international research group led by Osaka Metropolitan University researchers conducted a large-scale online survey of clinicians in the Asia-Pacific region to investigate treatment policies for ...